For RDCS<0h, the increased depression vulnerability may involve inflammatory activation impairing serotonin synthesis through the kynurenine pathway (23, 24), coupled with reduced Brain-Derived Neurotrophic Factor (BDNF) l levels that compromise neural plasticity and emotional regulation (25). The gene discussed is BDNF; the disease is depressive symptom measurement.